Aberrant expression of B-lymphocyte stimulator by B chronic lymphocytic leukemia cells: a mechanism for survival.

Abstract:

:B-cell chronic lymphocytic leukemia (B-CLL) is defined by the accumulation of CD5(+) B cells in the periphery and bone marrow. This disease is not characterized by highly proliferative cells but rather by the presence of leukemic cells with significant resistance to apoptosis and, therefore, prolonged survival. B-lymphocyte stimulator (BLyS) is a newly identified tumor necrosis factor (TNF) family member shown to be critical for maintenance of normal B-cell development and homeostasis and it shares significant homology with another TNF superfamily member, APRIL. The striking effects of BLyS on normal B-cell maintenance and survival raises the possibility that it may be involved in pathogenesis and maintenance of hematologic malignancies, including B-CLL. In this study, we investigated the status of APRIL and BLyS expression, as well as their receptors, in this disease. All B-CLL patient cells studied expressed one or more of 3 known receptors for BLyS; however, the pattern of expression was variable. In addition, we demonstrate for the first time that B-CLL cells from a subset of patients aberrantly express BLyS and APRIL mRNA, whereas these molecules were not detectable in normal B cells. Furthermore, we provide in vitro evidence that BLyS protects B-CLL cells from apoptosis and enhances cell survival. Because these molecules are key regulators of B-cell homeostasis and tumor progression, leukemic cell autocrine expression of BLyS and APRIL may be playing an important role in the pathogenesis of this disease.

journal_name

Blood

journal_title

Blood

authors

Novak AJ,Bram RJ,Kay NE,Jelinek DF

doi

10.1182/blood-2002-02-0558

subject

Has Abstract

pub_date

2002-10-15 00:00:00

pages

2973-9

issue

8

eissn

0006-4971

issn

1528-0020

journal_volume

100

pub_type

杂志文章

相关文献

BLOOD文献大全
  • A novel KIR-associated function: evidence that CpG DNA uptake and shuttling to early endosomes is mediated by KIR3DL2.

    abstract::Human natural killer (NK) cells express Toll-like receptor 9 (TLR9) transcript and, upon exposure to microbial CpG oligodeoxynucleotide (ODN), release cytokines and kill target cells. Here we show that NK cell treatment with CpG ODN results in down-modulation of KIR3DL2 inhibitory receptor from the cell surface and in...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-12-256586

    authors: Sivori S,Falco M,Carlomagno S,Romeo E,Soldani C,Bensussan A,Viola A,Moretta L,Moretta A

    更新日期:2010-09-09 00:00:00

  • Electrolyte and acid-base disturbances in the management of leukemia.

    abstract::Electrolyte disturbances in leukemia can be the result of the disease process or drug therapy. One group of electrolyte abnormalities is related to the stage of the leukemic process. Included in this group are newly diagnosed patients who may show elevated serum potassium, phosphorus, and magnesium--a result of their ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: O'Regan S,Carson S,Chesney RW,Drummond KN

    更新日期:1977-03-01 00:00:00

  • Caveolin-1 regulates TCR signal strength and regulatory T-cell differentiation into alloreactive T cells.

    abstract::Caveolin-1 (Cav-1) is a key organizer of membrane specializations and a scaffold protein that regulates signaling in multiple cell types. We found increased Cav-1 expression in human and murine T cells after allogeneic hematopoietic cell transplantation. Indeed, Cav-1(-/-)donor T cells caused less severe acute graft-v...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2015-09-672428

    authors: Schönle A,Hartl FA,Mentzel J,Nöltner T,Rauch KS,Prestipino A,Wohlfeil SA,Apostolova P,Hechinger AK,Melchinger W,Fehrenbach K,Guadamillas MC,Follo M,Prinz G,Ruess AK,Pfeifer D,del Pozo MA,Schmitt-Graeff A,Duyster J,H

    更新日期:2016-04-14 00:00:00

  • Id1, but not Id3, directs long-term repopulating hematopoietic stem-cell maintenance.

    abstract::E-proteins are widely expressed basic helix-loop-helix (HLH) transcription factors that regulate differentiation in many cell lineages, including lymphoid, muscle, and neuronal cells. E-protein function is controlled by HLH inhibitors such as Id and SCL/TAL1 proteins, which recently have been suggested to play a role ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-01-069914

    authors: Perry SS,Zhao Y,Nie L,Cochrane SW,Huang Z,Sun XH

    更新日期:2007-10-01 00:00:00

  • JAK2 inhibitors for myeloproliferative neoplasms: what is next?

    abstract::Since its approval in 2011, the Janus kinase 1/2 (JAK1/2) inhibitor ruxolitinib has evolved to become the centerpiece of therapy for myelofibrosis (MF), and its use in patients with hydroxyurea resistant or intolerant polycythemia vera (PV) is steadily increasing. Several other JAK2 inhibitors have entered clinical te...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2017-04-742288

    authors: Bose P,Verstovsek S

    更新日期:2017-07-13 00:00:00

  • Subunit structure of the erythropoietin receptor analyzed by 125I-Epo cross-linking in cells expressing wild-type or mutant receptors.

    abstract::To analyze the structure of the murine erythropoietin receptor (EpoR), wild-type or mutant EpoR cDNAs were expressed in cell lines, and the proteins that cross-linked with 125I-labeled erythropoietin (Epo) were analyzed by immunoprecipitation using an antibody against the intracellular region of the cloned EpoR. COS-7...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Miura O,Ihle JN

    更新日期:1993-04-01 00:00:00

  • Cell cycle analysis and synchronization of pluripotent hematopoietic progenitor stem cells.

    abstract::Hematopoietic stem cells purified from mouse bone marrow are quiescent with less than 2% of Lin- Hoechst(low)/Rhodamine(low) (Lin- Ho(low)/Rho(low)) and 10% to 15% of Lin-/Sca+ cells in S phase. These cells enter proliferative cycle and progress through G1 and into S phase in the presence of cytokines and 5% heat-inac...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Reddy GP,Tiarks CY,Pang L,Wuu J,Hsieh CC,Quesenberry PJ

    更新日期:1997-09-15 00:00:00

  • Polymorphisms of clotting factors modify the risk for primary intracranial hemorrhage.

    abstract::Intracranial hemorrhage is the third most frequent cause of cerebrovascular disease, but few genetic risk factors have been associated with its development. Recently, it has been reported that some polymorphisms that affect clotting factors increase the risk for thrombosis. However, reports have analyzed the effect of...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v97.10.2979

    authors: Corral J,Iniesta JA,González-Conejero R,Villalón M,Vicente V

    更新日期:2001-05-15 00:00:00

  • Exclusion of the first EGF domain of factor VII by a splice site mutation causes lethal factor VII deficiency.

    abstract::We have studied a family with homozygous lethal, blood coagulation factor VII (FVII) deficiency. To identify the mutation responsible for the deficiency, exons 2 to 8 and the intron-exon junctions of their FVII genes were amplified from peripheral white blood cell DNA by polymerase chain reaction and screened by singl...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: McVey JH,Boswell EJ,Takamiya O,Tamagnini G,Valente V,Fidalgo T,Layton M,Tuddenham EG

    更新日期:1998-08-01 00:00:00

  • The PI3K/mTOR inhibitor PF-04691502 induces apoptosis and inhibits microenvironmental signaling in CLL and the Eµ-TCL1 mouse model.

    abstract::Current treatment strategies for chronic lymphocytic leukemia (CLL) involve a combination of conventional chemotherapeutics, monoclonal antibodies, and targeted signaling inhibitors. However, CLL remains largely incurable, with drug resistance and treatment relapse a common occurrence, leading to the search for novel ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-11-610329

    authors: Blunt MD,Carter MJ,Larrayoz M,Smith LD,Aguilar-Hernandez M,Cox KL,Tipton T,Reynolds M,Murphy S,Lemm E,Dias S,Duncombe A,Strefford JC,Johnson PW,Forconi F,Stevenson FK,Packham G,Cragg MS,Steele AJ

    更新日期:2015-06-25 00:00:00

  • It takes a village.

    abstract::In this issue of Blood, Bhatia et al demonstrate the critical importance of an adherence to oral chemotherapy regimens in attaining cure for children with acute lymphoblastic leukemia (ALL) and identify race-specific determinants of adherence. ...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2014-05-576900

    authors: Winick N

    更新日期:2014-10-09 00:00:00

  • How I treat gastrointestinal bleeding in congenital and acquired von Willebrand disease.

    abstract::Gastrointestinal (GI) bleeding is distinctive of severe von Willebrand disease (VWD), generally arising in older patients; in most cases, blood transfusion and hospitalization are required. The presence of arteriovenous malformations is often described when endoscopic examinations are performed. Patients with congenit...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019003702

    authors: Biguzzi E,Siboni SM,Peyvandi F

    更新日期:2020-09-03 00:00:00

  • GATA1 mutations in transient leukemia and acute megakaryoblastic leukemia of Down syndrome.

    abstract::Children with constitutional trisomy 21 (Down syndrome) have an approximately 500-fold increased risk of developing acute megakaryoblastic leukemia (AMKL), a form of acute myeloid leukemia. Unique to newborn infants with Down syndrome is a transient leukemia (TL), also referred to as transient myeloproliferative syndr...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-01-0013

    authors: Hitzler JK,Cheung J,Li Y,Scherer SW,Zipursky A

    更新日期:2003-06-01 00:00:00

  • A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children's Cancer Group study.

    abstract::For this study, 118 children with standard-risk acute lymphoblastic leukemia (ALL) were given randomized assignments to receive native or pegylated Escherichia coli asparaginase as part of induction and 2 delayed intensification phases. Patients treated with pegaspargase had more rapid clearance of lymphoblasts from d...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1182/blood.v99.6.1986

    authors: Avramis VI,Sencer S,Periclou AP,Sather H,Bostrom BC,Cohen LJ,Ettinger AG,Ettinger LJ,Franklin J,Gaynon PS,Hilden JM,Lange B,Majlessipour F,Mathew P,Needle M,Neglia J,Reaman G,Holcenberg JS,Stork L

    更新日期:2002-03-15 00:00:00

  • The concerted action of GM-CSF and Flt3-ligand on in vivo dendritic cell homeostasis.

    abstract::Dendritic cell (DC) development is efficiently supported by Flt3-ligand or GM-CSF in vitro, and lymphoid-organ DC maintenance in vivo is critically dependent on Flt3-ligand. However, the relevance of GM-CSF for lymphoid-tissue DC maintenance and the importance of both cytokines for nonlymphoid organ DC homeostasis are...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-02-206318

    authors: Kingston D,Schmid MA,Onai N,Obata-Onai A,Baumjohann D,Manz MG

    更新日期:2009-07-23 00:00:00

  • A novel costimulatory signaling in human T lymphocytes by a splice variant of CD28.

    abstract::We have characterized a splice variant (isoform) of the human CD28 T cell costimulatory receptor. The nucleotide sequence of this CD28 isoform was identical to that of CD28 in the signal peptide, the transmembrane domain, and the cytoplasmic tail, but it was missing a large segment of the extracellular ligand-binding ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v99.6.2138

    authors: Hanawa H,Ma Y,Mikolajczak SA,Charles ML,Yoshida T,Yoshida R,Strathdee CA,Litchfield DW,Ochi A

    更新日期:2002-03-15 00:00:00

  • Autologous bone marrow transplantation after a long first remission for children with recurrent acute lymphoblastic leukemia.

    abstract::Fifty-one children with acute lymphoblastic leukemia (ALL) in second or subsequent remission after a first remission of at least 24 months underwent purged, autologous bone marrow transplantation (ABMT). Bone marrow was harvested in remission and purged in vitro with monoclonal antibodies specific for leukemia-associa...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Billett AL,Kornmehl E,Tarbell NJ,Weinstein HJ,Gelber RD,Ritz J,Sallan SE

    更新日期:1993-03-15 00:00:00

  • Mitochondrial clearance is regulated by Atg7-dependent and -independent mechanisms during reticulocyte maturation.

    abstract::Mitochondrial clearance is a well recognized but poorly understood biologic process, and reticulocytes, which undergo programmed mitochondrial clearance, provide a useful model to study this phenomenon. At the ultrastructural level, mitochondrial clearance resembles an autophagy-related process; however, the role of a...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-04-151639

    authors: Zhang J,Randall MS,Loyd MR,Dorsey FC,Kundu M,Cleveland JL,Ney PA

    更新日期:2009-07-02 00:00:00

  • Characterization of glucocorticoid receptors and glucocorticoid receptor mRNA in human leukemia cells: stabilization of the receptor by diisopropylfluorophosphate.

    abstract::We have shown that cytosol samples from human leukemia cells frequently contain glucocorticoid receptor fragments that have a mol wt (Mr) of approximately 52,000. In the present study we demonstrate that the Mr approximately 52,000-receptor fragments are derived from intact glucocorticoid receptors (Mr approximately 9...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Distelhorst CW,Miesfeld R

    更新日期:1987-03-01 00:00:00

  • Blood tests for the diagnosis of venous and arterial thrombosis.

    abstract::There are many reports in the literature of blood test abnormalities occurring in patients with venous or arterial thrombosis. Most of these have not used acceptable criteria for establishing an association between thrombosis and blood tests and, therefore, their interpretation is questionable. Recently, sensitive and...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:

    authors: Hirsh J

    更新日期:1981-01-01 00:00:00

  • PEBP2-beta/CBF-beta-dependent phosphorylation of RUNX1 and p300 by HIPK2: implications for leukemogenesis.

    abstract::The heterodimeric transcription factor RUNX1/PEBP2-beta (also known as AML1/CBF-beta) is essential for definitive hematopoiesis. Here, we show that interaction with PEBP2-beta leads to the phosphorylation of RUNX1, which in turn induces p300 phosphorylation. This is mediated by homeodomain interacting kinase 2 (HIPK2)...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-01-134122

    authors: Wee HJ,Voon DC,Bae SC,Ito Y

    更新日期:2008-11-01 00:00:00

  • Expression, localization, and regulation of NOS in human mast cell lines: effects on leukotriene production.

    abstract::Nitric oxide (NO) is a potent radical produced by nitric oxide synthase (NOS) and has pleiotrophic activities in health and disease. As mast cells (MCs) play a central role in both homeostasis and pathology, we investigated NOS expression and NO production in human MC populations. Endothelial NOS (eNOS) was ubiquitous...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-08-2990

    authors: Gilchrist M,McCauley SD,Befus AD

    更新日期:2004-07-15 00:00:00

  • Ikaros is required for plasmacytoid dendritic cell differentiation.

    abstract::Plasmacytoid dendritic cells (pDCs) are specialized DCs that produce high levels of type I IFN upon viral infection. Despite their key immunoregulatory role, little is known about pDC ontogeny or how developmental events regulate their function. We show that mice expressing low levels of the transcription factor Ikaro...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-03-007757

    authors: Allman D,Dalod M,Asselin-Paturel C,Delale T,Robbins SH,Trinchieri G,Biron CA,Kastner P,Chan S

    更新日期:2006-12-15 00:00:00

  • Midostaurin, enasidenib, CPX-351, gemtuzumab ozogamicin, and venetoclax bring new hope to AML.

    abstract::In 2017, 4 drugs received US Food and Drug Administration marketing approval for acute myeloid leukemia (AML) treatment: targeted therapies for mutant FLT3 and IDH2, a liposomal cytarabine-daunorubicin formulation for therapy-related AML and AML with myelodysplasia-related changes, and resurgence of an antibody-drug c...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2017-08-784066

    authors: Wei AH,Tiong IS

    更新日期:2017-12-07 00:00:00

  • Tyrosine phosphorylation of guanosine triphosphatase activating protein by activation via surface IgG in human B cells.

    abstract::In this study, we analyzed tyrosine phosphorylation of guanosine triphosphatase (GTPase) activating protein in human B cells stimulated through surface IgG, using Western blot and immunoprecipitation. Stimulation through surface IgG induced the tyrosine phosphorylation of GTPase-activating protein (GAP) and two associ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Yagura H,Oyaizu N,Pahwa S

    更新日期:1993-03-15 00:00:00

  • Administration of interleukin-2 (IL-2) results in increased plasma concentrations of IL-5 and eosinophilia in patients with cancer.

    abstract::Peripheral eosinophilia is almost invariably observed during the course of interleukin-2 (IL-2) therapy and is frequently accompanied by the development of a capillary leak syndrome characterized by edema, weight gain, and oliguria. We studied five patients with advanced malignancy treated with IL-2. Eosinophilia was ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: van Haelst Pisani C,Kovach JS,Kita H,Leiferman KM,Gleich GJ,Silver JE,Dennin R,Abrams JS

    更新日期:1991-09-15 00:00:00

  • A prospective study of serum soluble CD30 concentration and risk of non-Hodgkin lymphoma.

    abstract::Prediagnostic serum concentration of soluble CD30 (sCD30), a marker for chronic B-cell stimulation, has been associated with increased risk of developing AIDS-related non-Hodgkin lymphoma (NHL) in a recent study of HIV(+) patients. To investigate among healthy persons whether serum sCD30 is associated with NHL risk, w...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究

    doi:10.1182/blood-2009-04-217521

    authors: Purdue MP,Lan Q,Martinez-Maza O,Oken MM,Hocking W,Huang WY,Baris D,Conde B,Rothman N

    更新日期:2009-09-24 00:00:00

  • Differential requirements for the O-linked branching enzyme core 2 beta1-6-N-glucosaminyltransferase in biosynthesis of ligands for E-selectin and P-selectin.

    abstract::Selectins are carbohydrate-binding adhesion molecules that play important roles in control of leukocyte traffic. Glycosyltransferases involved in selectin ligand biosynthesis include the alpha1,3-fucosyltransferases FucT-VII and FucT-IV, one or more sialyltransferases, and at least one O-linked branching enzyme. Previ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v97.12.3806

    authors: Snapp KR,Heitzig CE,Ellies LG,Marth JD,Kansas GS

    更新日期:2001-06-15 00:00:00

  • Relapse after non-T-cell-depleted allogeneic bone marrow transplantation for chronic myelogenous leukemia: early transplantation, use of an unrelated donor, and chronic graft-versus-host disease are protective.

    abstract::We analyzed the incidence of posttransplant chronic myelogenous leukemia (CML) relapse in 283 consecutive related-donor (n = 177) and unrelated-donor (n = 106) allogeneic transplant recipients. Twenty-two of 165 related-donor recipients with stable or advanced disease at the time of transplant had hematologic relapse ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Enright H,Davies SM,DeFor T,Shu X,Weisdorf D,Miller W,Ramsay NK,Arthur D,Verfaillie C,Miller J,Kersey J,McGlave P

    更新日期:1996-07-15 00:00:00

  • Successful bone marrow transplantation against mixed lymphocyte culture barrier.

    abstract::If bone marrow transplantation is to become widely applicable in the treatment of patients with leukemia and aplastic anemia, the necessity to have a perfectly histocompatible donor must be overcome. In an effort to define the roles of HL-A type and mixed lymphocyte culture (MLC) reactivity in the determination of suc...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Feig SA,Opelz G,Winter HS,Falk PM,Neerhout RC,Sparkes R,Gale RP

    更新日期:1976-09-01 00:00:00